ERK1-mediated immunomodulation of mesenchymal stem cells ameliorates inflammatory disorders

Immune system disorders, especially T cell disorders, are important therapeutic targets of mesenchymal stem cells (MSCs) in many autoimmune diseases (ADs). Although extracellular regulated protein kinases (ERKs) play a role in MSC therapy by promoting T cell apoptosis, the mechanism remains unclear....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qing, Lei, Xiao, Wang, Fang, He, Xiaoning, Liu, Lu, Hou, Yuxia, Liu, Yuan, Jin, Fang, Chen, Chider, Li, Bei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543658/
https://www.ncbi.nlm.nih.gov/pubmed/37790278
http://dx.doi.org/10.1016/j.isci.2023.107868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543658/
https://www.ncbi.nlm.nih.gov/pubmed/37790278
http://dx.doi.org/10.1016/j.isci.2023.107868

Ejemplares similares